Desflurane Versus Propofol in the Sitting Position
Information source: Gachon University Gil Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cerebral Ischemia
Intervention: propofol (Drug); Desflurane (Drug); alfentanil (Drug); Rocuronium (Drug)
Phase: N/A
Status: Completed
Sponsored by: Gachon University Gil Medical Center Official(s) and/or principal investigator(s):
Hyun Jeong Kwak, MD.PhD, Study Director, Affiliation: Gachon University Gil Hospital
Summary
The investigators hypothesized that both propofol and desflurane would decrease the regional
oxygen saturation (rSO2) but propofol is likely to reduce rSO2 more than sevoflurane when
patients are raised to the sitting position.
Clinical Details
Official title: International Review Board of Gachon University Gil Hospital
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention
Primary outcome: Regional Cerebral Oxygen Satuation (rSO2)
Detailed description:
The investigators hypothesized that both propofol and desflurane would decrease the rSO2 but
propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the
sitting position. Therefore, the purpose of this study was to investigate the effect of
desflurane and propofol on rSO2 values during the beach chair position for shoulder
arthroscopy.
Eligibility
Minimum age: 20 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Forty patients,
- ASA class I or II,
- undergoing shoulder arthroscopy
Exclusion Criteria:
- Patients with history of cerebrovascular disease, coronary occlusive disease and/or
obesity (body mass index > 30) were excluded from this study.
Locations and Contacts
Additional Information
Starting date: March 2011
Last updated: August 25, 2013
|
